51. Case report: Neoadjuvant systemic therapy for melanoma
- Author
-
Natiya Gabuniya, Ankur Khajuria, Jenny L. C. Geh, and Daniah Alsaadi
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Neoadjuvant systemic therapy ,Disease ,Systemic therapy ,Advanced metastatic melanoma ,Lesion ,03 medical and health sciences ,0302 clinical medicine ,Case report ,medicine ,Skin cancer ,Chemotherapy ,business.industry ,Melanoma ,Treatment options ,General Medicine ,medicine.disease ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Surgery ,Histopathology ,Radiology ,medicine.symptom ,business - Abstract
We report a case of rapidly enlarging metastatic melanoma in 45-year-old White male following primary resection of thin melanoma five years ago. Location and large size of the lesion possessed significant risk of complications from surgery, therefore provided a challenge in treatment options. Neoadjuvant targeted chemotherapy was commenced and resulted in a significant reduction in size of the lesion, which allowed subsequent safe surgical resection with no residual disease on histopathology results. This case provides a good example of successful utilization of neoadjuvant systemic therapy in advanced metastatic melanoma., Highlights • Outline of advanced metastatic melanoma presentation. • Successful treatment with neoadjuvant therapy that aided surgical resection and achieved disease free results on follow up. • Overall improved survival and remission of patient with advanced disease.
- Published
- 2020